239 related articles for article (PubMed ID: 37793406)
1. Brazilian experts' consensus on the treatment of infantile epileptic spasm syndrome in infants.
Sampaio LPB; Henriques-Souza AMM; Silveira MRMD; Seguti L; Santos MLSF; Montenegro MA; Antoniuk S; Manreza MLG
Arq Neuropsiquiatr; 2023 Sep; 81(9):844-856. PubMed ID: 37793406
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome.
Sánchez Fernández I; Amengual-Gual M; Barcia Aguilar C; Romeu A; Sheikh T; Torres A; Chao J; Jonas R; Gaínza-Lein M; Harini C; Douglass L
Epilepsia; 2023 Mar; 64(3):630-640. PubMed ID: 36600453
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
4. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
[TBL] [Abstract][Full Text] [Related]
5. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD
Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852
[TBL] [Abstract][Full Text] [Related]
6. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.
Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A
Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538
[TBL] [Abstract][Full Text] [Related]
7. Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG.
Deckard E; Sathe R; Tabibzadeh D; Terango A; Groves A; Rajaraman RR; Nariai H; Hussain SA
Epilepsia Open; 2024 Jun; 9(3):1034-1041. PubMed ID: 38588009
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
[TBL] [Abstract][Full Text] [Related]
10. Response to sequential treatment with prednisolone and vigabatrin in infantile spasms.
Dzau W; Cheng S; Snell P; Fahey M; Scheffer IE; Harvey AS; Howell KB
J Paediatr Child Health; 2022 Dec; 58(12):2197-2202. PubMed ID: 36054157
[TBL] [Abstract][Full Text] [Related]
11. Real-life data comparing the efficacy of vigabatrin and oral steroids given sequentially or combined for infantile epileptic spasms syndrome.
Dozieres-Puyravel B; Nasser H; Mauvais FX; De Saint Martin A; Perriard C; Di Meglio C; Cances C; Hachon-LE Camus C; Milh M; Auvin S
Eur J Paediatr Neurol; 2024 Jan; 48():61-66. PubMed ID: 38041897
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
Prezioso G; Chiarelli F; Matricardi S
Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
[TBL] [Abstract][Full Text] [Related]
13. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
[TBL] [Abstract][Full Text] [Related]
14. Treatment with High-Dose Prednisolone in Vigabatrin-Refractory Infantile Spasms.
Al-Shehhi W; Chau V; Boyd J; Snead C; Sharma R; Donner E; Go C; Jain P
Can J Neurol Sci; 2022 Jul; 49(4):532-539. PubMed ID: 34212837
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
16. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
[TBL] [Abstract][Full Text] [Related]
17. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
18. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
[TBL] [Abstract][Full Text] [Related]
19. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
Jones K; Snead OC; Boyd J; Go C
J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
[TBL] [Abstract][Full Text] [Related]
20. Medication selection, health services outcomes, and cost trajectories for Medicaid beneficiaries with infantile spasms.
Min JY; Knupp KG; Patel AD; Shellhaas RA; Zhang M; Grinspan ZM
Epilepsy Res; 2021 Oct; 176():106733. PubMed ID: 34333373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
